Hyaluronan regulates transforming growth factor-beta1 receptor compartmentalization

Area of Science:

• Cell Biology
• Molecular Biology
• Renal Physiology

Background:

• Transforming growth factor-beta1 (TGF-beta1) drives fibrosis.
• Hyaluronan (HA) and CD44 interaction previously shown to reduce TGF-beta1 signaling in kidney cells.
• The precise mechanism of HA-CD44 regulation of TGF-beta receptor function requires elucidation.

Purpose of the Study:

• To investigate the mechanism by which hyaluronan (HA) and CD44 interaction regulates TGF-beta receptor function.
• To determine the role of membrane microdomains (lipid rafts) in TGF-beta receptor trafficking and signaling.
• To explore the impact of HA-CD44 engagement on Smad protein activation and receptor turnover.

Main Methods:

• Affinity labeling to track TGF-beta receptor localization in membrane pools (lipid rafts vs. non-lipid rafts).
• Analysis of Smad protein association with EEA-1 and caveolin-1.
• Manipulation of membrane cholesterol levels (nystatin) and endocytosis to assess effects on receptor trafficking.
• Inhibition of HA-CD44 interaction and MAP kinase activation.

Main Results:

• Exogenous HA induced TGF-beta receptors to partition into caveolin-1-associated lipid rafts.
• HA promoted association of Smad7 with caveolin-1-bound receptors, indicating enhanced receptor turnover.
• TGF-beta1 signaling (Smad activation) was attenuated by HA, linked to raft localization and increased receptor turnover.
• HA-induced receptor trafficking to rafts was dependent on HA-CD44 interaction and MAP kinase activation.

Conclusions:

• HA engagement of CD44 promotes TGF-beta receptor trafficking to lipid rafts via a MAP kinase-dependent pathway.
• This trafficking facilitates increased receptor turnover, leading to attenuation of TGF-beta1 signaling in proximal tubular cells.
• The findings propose a novel mechanism for regulating TGF-beta1-mediated fibrosis through modulation of receptor localization and turnover.